At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non Interventional, Retrospective Study on Real World Usage and Treatment Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to the SIADH.
In Brief
An observational study for Hyponatremia and Syndrome of Inappropriate ADH (SIADH) Secretion. Completed, enrolled 100 participants across 7 sites in 2 countries.
Detailed Summary
This is a retrospective chart review non-interventional study designed to collect real world data on the use and outcomes of tolvaptan for the treatment of patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone (SIADH) secretion.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany, Spain
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 2015
Enrollment StartNov 2015
Primary CompletionApr 2016
TodayJul 2026
First PostedSep 9, 2015
Enrollment StartNov 1, 2015
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.8 years ago